Fibrotic Interstitial Lung Disease Clinical Trials
2 recruiting trials for Fibrotic Interstitial Lung Disease. Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
2
Sponsors
Recruiting Trials
RECRUITINGNCT07486206
Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 Trial
The OPTIMIZE-ILD-2 trial is a prospective, randomized, open-label clinical trial designed to evaluate the impact of a coordinated follow-up pathway on patients with established...
Sponsor: Hospital de GranollersEnrolling: 1521 location
RECRUITINGPhase 2NCT06053164
Ambulatory Oxygen Therapy for Individuals With Mild-to-moderate Interstitial Lung Disease
The investigators plan to conduct a study to find out if giving portable oxygen therapy (during physical activity) to patients with interstitial lung disease will improve quality...
Sponsor: University of AlbertaEnrolling: 601 location